Condition: Complete Heart Block · Second Degree Atrioventricular Block Möbitz Type II · Sponsor: Institut d'Investigació Biomèdica de Bellvitge
Multicenter randomized controlled trial which will include patients with left ventricular ejection fraction \>50% requiring a first implant of a cardiac pacemaker with expected high pacing percentages. Patients will be randomized 1:1 to right ventricular apical pacing vs left septal or deep septal pacing. The primary endpoint will be pacing-induced cardiomyopathy during the first year of follow-up.
This description comes directly from the study's public registry record.
Andrea Di Marco, MD, PhD · +34932 60 75 00 · adimarco@bellvitgehospital.cat
Always discuss trial participation with your own doctor first.
| Hospital Vall d'Hebrón | Barcelona, Spain | Not Yet Recruiting |
| Hospital General Universitario de Castellón | Castellon, Spain | Not Yet Recruiting |
| Hospital Virgen de las Nieves | Granada, Spain | Not Yet Recruiting |
| Hospital Universitario de Bellvitge | L'Hospitalet de Llobregat, Spain | Recruiting |
| Hospital La Fe | Valencia, Spain | Not Yet Recruiting |
| Hospital Lozano Blesa | Zaragoza, Spain | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06474819